|
Event Registration for Industry Professionals | Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced NSCLC — September 15, 2019, Chicago, ILThis activity is intended for radiation oncologists, medical oncologists, oncology fellows and other healthcare providers involved in the treatment of lung cancer. |